Dimensional Fund Advisors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-72,997
Closed -$380K 3357
2016
Q4
$380K Sell
72,997
-1,124
-2% -$5.28K ﹤0.01% 3131
2016
Q3
$346K Buy
74,121
+21,586
+41% +$101K ﹤0.01% 3117
2016
Q2
$207K Buy
52,535
+7,086
+16% +$26.5K ﹤0.01% 3175
2016
Q1
$141K Buy
45,449
+2,800
+7% +$9.38K ﹤0.01% 3214
2015
Q4
$195K Buy
42,649
+8,643
+25% +$41K ﹤0.01% 3220
2015
Q3
$160K Buy
34,006
+4,800
+16% +$31K ﹤0.01% 3260
2015
Q2
$209K Buy
29,206
+9,470
+48% +$71.2K ﹤0.01% 3244
2015
Q1
$167K Buy
+19,736
New +$168K ﹤0.01% 3244

Other funds holding DSCI

Dimensional Fund Advisors's DSCI Position: Q1 2017 in Review

Dimensional Fund Advisors sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 72,997 shares — an estimated $380K sold.

Dimensional Fund Advisors first reported a position in DSCI in Q1 2015 and held it in 8 quarters. The position peaked at $380K in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Dimensional Fund Advisors reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Dimensional Fund Advisors sold 72,997 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $380K.
  • Dimensional Fund Advisors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2015 and held it in 8 quarters.
  • Dimensional Fund Advisors's Derma Sciences, Inc. Common Stock (DE) position peaked at $380K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Dimensional Fund Advisors's 13F filing for Q1 2017, filed 12 May 2017.